Phenotypic Assay

Table P1. Single Targets Enriched Among Active molecules

  • kA:The number of active compounds known to target the gene
  • KA:The total number of active compounds(IC50 < 10-6)
  • kB:The number of inactive compounds known to target the gene
  • KB:The total number of inactive compounds(IC50 >10-6)
  • Odds Ratio: (kA/kB) / ( (KA-kA) / (KB - kB) )
# Target (Gene) P-value
FDR adjusted
Odds Ratio kA KA kB KB Polypharmacology
report
View
Compounds
details
View Target Profile
1 MITF 0. 84.0 528 2011 439 103975 Polypharmacology Molecules Target Profile
2 HSPA1A 2.48e-33 67.4 27 2011 21 103975 Polypharmacology Molecules Target Profile
3 ATXN2 0. 67.3 456 2011 451 103975 Polypharmacology Molecules Target Profile
4 EPAS1 0. 42.3 405 2011 616 103975 Polypharmacology Molecules Target Profile
5 HIF1A 1.66e-298 40.2 288 2011 431 103975 Polypharmacology Molecules Target Profile
6 PLIN1 3.93e-21 34.8 20 2011 30 103975 Polypharmacology Molecules Target Profile
7 AGTR1 1.72e-33 32.7 33 2011 53 103975 Polypharmacology Molecules Target Profile
8 CFTR 0. 30.6 377 2011 777 103975 Polypharmacology Molecules Target Profile
9 GALK1 1.90e-10 28.9 10 2011 18 103975 Polypharmacology Molecules Target Profile
10 OPRK1 6.78e-44 28.0 46 2011 87 103975 Polypharmacology Molecules Target Profile
11 HNF4A 3.09e-183 27.6 199 2011 412 103975 Polypharmacology Molecules Target Profile
12 TNF 8.45e-201 27.1 220 2011 469 103975 Polypharmacology Molecules Target Profile
13 NCOA3 1.43e-118 25.7 131 2011 281 103975 Polypharmacology Molecules Target Profile
14 NOD2 2.27e-209 24.5 239 2011 570 103975 Polypharmacology Molecules Target Profile
15 SMAD3 0. 24.0 381 2011 1003 103975 Polypharmacology Molecules Target Profile
16 RAD52 6.02e-31 23.8 34 2011 75 103975 Polypharmacology Molecules Target Profile
17 CXCR6 6.92e-114 21.9 134 2011 338 103975 Polypharmacology Molecules Target Profile
18 NOD1 5.36e-275 21.4 335 2011 962 103975 Polypharmacology Molecules Target Profile
19 XBP1 4.94e-63 21.3 74 2011 186 103975 Polypharmacology Molecules Target Profile
20 IDH1 0. 21.1 552 2011 1835 103975 Polypharmacology Molecules Target Profile
21 NCOA1 1.61e-52 20.8 62 2011 159 103975 Polypharmacology Molecules Target Profile
22 NTSR1 2.58e-61 20.6 73 2011 190 103975 Polypharmacology Molecules Target Profile
23 PAX8 1.05e-151 20.5 185 2011 512 103975 Polypharmacology Molecules Target Profile
24 NCOA2 1.12e-63 19.3 78 2011 217 103975 Polypharmacology Molecules Target Profile
25 CYP19A1 1.30e-15 19.2 18 2011 49 103975 Polypharmacology Molecules Target Profile
26 IL1B 0. 19.0 976 2011 4926 103975 Polypharmacology Molecules Target Profile
27 CCR6 7.92e-135 18.4 172 2011 527 103975 Polypharmacology Molecules Target Profile
28 ADRB2 4.08e-145 18.3 186 2011 577 103975 Polypharmacology Molecules Target Profile
29 S1PR1 8.80e-85 16.6 112 2011 368 103975 Polypharmacology Molecules Target Profile
30 TLR9 1.64e-56 15.6 76 2011 261 103975 Polypharmacology Molecules Target Profile
31 HKDC1 4.43e-47 15.1 64 2011 226 103975 Polypharmacology Molecules Target Profile
32 RAD54L 1.80e-28 15.0 38 2011 133 103975 Polypharmacology Molecules Target Profile
33 BCL2L2 3.14e-08 14.8 10 2011 35 103975 Polypharmacology Molecules Target Profile
34 S1PR4 2.47e-108 14.3 155 2011 603 103975 Polypharmacology Molecules Target Profile
35 GMNN 0. 13.2 814 2011 5099 103975 Polypharmacology Molecules Target Profile
36 TLR4 5.86e-36 13.1 52 2011 210 103975 Polypharmacology Molecules Target Profile
37 TDP1 0. 12.9 1545 2011 21212 103975 Polypharmacology Molecules Target Profile
38 NR5A2 3.23e-80 12.8 121 2011 519 103975 Polypharmacology Molecules Target Profile
39 FEN1 1.80e-46 12.7 69 2011 290 103975 Polypharmacology Molecules Target Profile
40 JAK2 2.26e-154 12.7 239 2011 1094 103975 Polypharmacology Molecules Target Profile
41 GALR2 1.48e-139 12.6 216 2011 984 103975 Polypharmacology Molecules Target Profile
42 ATM 1.06e-19 12.0 29 2011 127 103975 Polypharmacology Molecules Target Profile
43 VDR 1.34e-127 11.8 204 2011 983 103975 Polypharmacology Molecules Target Profile
44 NPSR1 1.54e-168 11.7 274 2011 1378 103975 Polypharmacology Molecules Target Profile
45 PAFAH1B3 6.43e-39 11.7 60 2011 272 103975 Polypharmacology Molecules Target Profile
46 APLNR 1.22e-65 11.6 104 2011 488 103975 Polypharmacology Molecules Target Profile
47 RBBP8 7.60e-67 11.6 106 2011 498 103975 Polypharmacology Molecules Target Profile
48 KLF5 1.09e-28 11.5 44 2011 201 103975 Polypharmacology Molecules Target Profile
49 MAP1LC3A 1.85e-131 11.5 214 2011 1066 103975 Polypharmacology Molecules Target Profile
50 TNFRSF10B 1.81e-144 11.4 237 2011 1201 103975 Polypharmacology Molecules Target Profile
51 CASP1 3.12e-57 11.2 92 2011 444 103975 Polypharmacology Molecules Target Profile
52 MDM2 2.59e-15 11.1 23 2011 108 103975 Polypharmacology Molecules Target Profile
53 UBE2N 5.61e-42 11.1 67 2011 322 103975 Polypharmacology Molecules Target Profile
54 GPR55 2.84e-30 10.6 49 2011 245 103975 Polypharmacology Molecules Target Profile
55 MAP4K2 5.22e-126 10.1 222 2011 1263 103975 Polypharmacology Molecules Target Profile
56 NR2E3 1.99e-69 9.8 122 2011 682 103975 Polypharmacology Molecules Target Profile
57 SIX1 4.08e-64 9.7 113 2011 635 103975 Polypharmacology Molecules Target Profile
58 S1PR2 3.23e-52 9.3 94 2011 548 103975 Polypharmacology Molecules Target Profile
59 STK33 4.57e-17 9.2 29 2011 165 103975 Polypharmacology Molecules Target Profile
60 MCHR1 6.90e-50 9.0 91 2011 542 103975 Polypharmacology Molecules Target Profile
61 BCL2 1.50e-07 8.9 12 2011 70 103975 Polypharmacology Molecules Target Profile
62 GPR35 5.76e-07 8.8 11 2011 65 103975 Polypharmacology Molecules Target Profile
63 NR2F2 1.10e-60 8.8 114 2011 708 103975 Polypharmacology Molecules Target Profile
64 NLRP1 8.13e-86 8.7 164 2011 1047 103975 Polypharmacology Molecules Target Profile
65 USP1 5.38e-26 8.5 48 2011 299 103975 Polypharmacology Molecules Target Profile
66 MLLT3 3.02e-17 8.5 31 2011 192 103975 Polypharmacology Molecules Target Profile
67 DCLRE1C 3.97e-16 8.0 30 2011 197 103975 Polypharmacology Molecules Target Profile
68 MMP14 4.18e-40 7.7 81 2011 563 103975 Polypharmacology Molecules Target Profile
69 GSTO1 2.41e-87 7.7 183 2011 1335 103975 Polypharmacology Molecules Target Profile
70 AR 1.02e-11 7.6 22 2011 151 103975 Polypharmacology Molecules Target Profile
71 BLM 1.28e-22 7.5 45 2011 315 103975 Polypharmacology Molecules Target Profile
72 APP 1.65e-126 7.5 276 2011 2161 103975 Polypharmacology Molecules Target Profile
73 NPBWR1 2.50e-79 7.4 170 2011 1277 103975 Polypharmacology Molecules Target Profile
74 KCNJ1 9.14e-91 7.4 196 2011 1492 103975 Polypharmacology Molecules Target Profile
75 LARGE 8.32e-17 7.1 34 2011 250 103975 Polypharmacology Molecules Target Profile
76 TNFSF10 1.03e-29 7.1 63 2011 473 103975 Polypharmacology Molecules Target Profile
77 PRNP 3.23e-32 7.0 69 2011 523 103975 Polypharmacology Molecules Target Profile
78 BCL2A1 5.96e-12 7.0 24 2011 180 103975 Polypharmacology Molecules Target Profile
79 NLRP3 2.61e-27 6.7 60 2011 474 103975 Polypharmacology Molecules Target Profile
80 OXTR 1.78e-28 6.7 63 2011 501 103975 Polypharmacology Molecules Target Profile
81 RGS4 9.38e-84 6.5 200 2011 1732 103975 Polypharmacology Molecules Target Profile
82 APAF1 4.79e-60 6.5 142 2011 1209 103975 Polypharmacology Molecules Target Profile
83 NFE2L2 1.12e-135 6.4 341 2011 3219 103975 Polypharmacology Molecules Target Profile
84 GAPDH 1.46e-50 6.4 120 2011 1027 103975 Polypharmacology Molecules Target Profile
85 UCHL5 3.77e-19 6.3 43 2011 357 103975 Polypharmacology Molecules Target Profile
86 HTT 8.21e-135 6.3 342 2011 3265 103975 Polypharmacology Molecules Target Profile
87 WRN 9.61e-28 6.2 65 2011 556 103975 Polypharmacology Molecules Target Profile
88 GPR183 8.05e-53 6.1 130 2011 1162 103975 Polypharmacology Molecules Target Profile
89 PPP1CA 2.10e-51 6.1 127 2011 1141 103975 Polypharmacology Molecules Target Profile
90 NFKB1 1.19e-19 6.0 46 2011 401 103975 Polypharmacology Molecules Target Profile
91 ABCB1 1.08e-10 6.0 24 2011 210 103975 Polypharmacology Molecules Target Profile
92 HTR1A 7.58e-31 5.9 76 2011 687 103975 Polypharmacology Molecules Target Profile
93 PADI4 9.83e-27 5.8 66 2011 602 103975 Polypharmacology Molecules Target Profile
94 MAPT 1.58e-125 5.8 343 2011 3559 103975 Polypharmacology Molecules Target Profile
95 HSP90AA1 1.65e-52 5.8 136 2011 1291 103975 Polypharmacology Molecules Target Profile
96 HTR5A 1.27e-35 5.7 91 2011 854 103975 Polypharmacology Molecules Target Profile
97 GLP1R 1.01e-74 5.7 201 2011 1999 103975 Polypharmacology Molecules Target Profile
98 VCP 6.80e-17 5.6 42 2011 398 103975 Polypharmacology Molecules Target Profile
99 AVPR1A 2.23e-13 5.5 33 2011 314 103975 Polypharmacology Molecules Target Profile
100 IDE 9.27e-25 5.4 65 2011 638 103975 Polypharmacology Molecules Target Profile
101 CTSL1 3.34e-27 5.4 72 2011 710 103975 Polypharmacology Molecules Target Profile
102 MAPK1 2.08e-25 5.4 67 2011 660 103975 Polypharmacology Molecules Target Profile
103 NPY2R 2.13e-64 5.2 186 2011 1994 103975 Polypharmacology Molecules Target Profile
104 DLD 1.25e-25 5.2 70 2011 716 103975 Polypharmacology Molecules Target Profile
105 HTR1E 2.98e-32 5.1 91 2011 955 103975 Polypharmacology Molecules Target Profile
106 KCNQ1 2.81e-71 5.1 212 2011 2349 103975 Polypharmacology Molecules Target Profile
107 APOBEC3F 2.44e-18 5.1 50 2011 520 103975 Polypharmacology Molecules Target Profile
108 DNMT1 3.26e-37 5.1 107 2011 1142 103975 Polypharmacology Molecules Target Profile
109 NCF1 3.57e-23 5.0 65 2011 687 103975 Polypharmacology Molecules Target Profile
110 S1PR3 1.31e-11 5.0 31 2011 326 103975 Polypharmacology Molecules Target Profile
111 GALR3 5.19e-17 5.0 47 2011 499 103975 Polypharmacology Molecules Target Profile
112 ACP1 1.54e-07 4.9 19 2011 200 103975 Polypharmacology Molecules Target Profile
113 PREPL 4.07e-28 4.9 82 2011 895 103975 Polypharmacology Molecules Target Profile
114 POLI 1.77e-35 4.9 106 2011 1178 103975 Polypharmacology Molecules Target Profile
115 NPY1R 7.83e-58 4.8 180 2011 2082 103975 Polypharmacology Molecules Target Profile
116 NR5A1 1.08e-53 4.8 168 2011 1952 103975 Polypharmacology Molecules Target Profile
117 NR3C1 0.00021 4.8 10 2011 109 103975 Polypharmacology Molecules Target Profile
118 MC4R 1.42e-56 4.8 178 2011 2081 103975 Polypharmacology Molecules Target Profile
119 HCRTR1 1.66e-70 4.7 226 2011 2702 103975 Polypharmacology Molecules Target Profile
120 ASAP1 3.27e-08 4.7 22 2011 243 103975 Polypharmacology Molecules Target Profile
121 CHRM4 1.54e-43 4.7 137 2011 1600 103975 Polypharmacology Molecules Target Profile
122 L3MBTL1 3.86e-18 4.6 54 2011 615 103975 Polypharmacology Molecules Target Profile
123 TDP2 3.04e-10 4.6 29 2011 328 103975 Polypharmacology Molecules Target Profile
124 CHRM5 2.79e-33 4.6 105 2011 1233 103975 Polypharmacology Molecules Target Profile
125 PPP5C 6.87e-09 4.6 25 2011 286 103975 Polypharmacology Molecules Target Profile
126 THRB 1.54e-08 4.5 24 2011 276 103975 Polypharmacology Molecules Target Profile
127 TP53 1.48e-29 4.5 94 2011 1116 103975 Polypharmacology Molecules Target Profile
128 PPME1 3.85e-21 4.5 66 2011 780 103975 Polypharmacology Molecules Target Profile
129 DRD3 1.22e-96 4.4 347 2011 4694 103975 Polypharmacology Molecules Target Profile
130 CBX1 2.72e-18 4.3 59 2011 725 103975 Polypharmacology Molecules Target Profile
131 SUMO1 6.44e-09 4.3 27 2011 331 103975 Polypharmacology Molecules Target Profile
132 HRAS 0.00027 4.2 11 2011 137 103975 Polypharmacology Molecules Target Profile
133 CYP1A2 2.30e-05 4.1 15 2011 188 103975 Polypharmacology Molecules Target Profile
134 MPI 7.50e-31 4.1 109 2011 1424 103975 Polypharmacology Molecules Target Profile
135 ITGA4 2.61e-11 4.1 37 2011 474 103975 Polypharmacology Molecules Target Profile
136 CYP3A4 6.40e-07 3.9 22 2011 293 103975 Polypharmacology Molecules Target Profile
137 SNCA 0.00015 3.9 13 2011 174 103975 Polypharmacology Molecules Target Profile
138 GNA15 2.27e-19 3.8 72 2011 999 103975 Polypharmacology Molecules Target Profile
139 TLR3 1.93e-05 3.8 17 2011 234 103975 Polypharmacology Molecules Target Profile
140 APOBEC3G 4.74e-19 3.8 72 2011 1014 103975 Polypharmacology Molecules Target Profile
141 CASP6 6.43e-05 3.8 15 2011 207 103975 Polypharmacology Molecules Target Profile
142 PSMD14 4.48e-17 3.8 64 2011 901 103975 Polypharmacology Molecules Target Profile
143 SELE 2.85e-13 3.8 49 2011 687 103975 Polypharmacology Molecules Target Profile
144 RAPGEF4 3.87e-06 3.7 20 2011 278 103975 Polypharmacology Molecules Target Profile
145 COPS5 3.63e-09 3.7 33 2011 468 103975 Polypharmacology Molecules Target Profile
146 STAT3 4.08e-42 3.6 178 2011 2698 103975 Polypharmacology Molecules Target Profile
147 ALOX12 9.04e-05 3.6 15 2011 214 103975 Polypharmacology Molecules Target Profile
148 CHRM1 1.84e-30 3.6 126 2011 1880 103975 Polypharmacology Molecules Target Profile
149 POLH 5.68e-23 3.6 93 2011 1374 103975 Polypharmacology Molecules Target Profile
150 GNAS 1.11e-05 3.6 19 2011 274 103975 Polypharmacology Molecules Target Profile
151 HDAC3 0.000109 3.6 15 2011 218 103975 Polypharmacology Molecules Target Profile
152 TAAR1 1.10e-40 3.6 176 2011 2717 103975 Polypharmacology Molecules Target Profile
153 MCOLN3 8.96e-07 3.6 24 2011 351 103975 Polypharmacology Molecules Target Profile
154 RBBP9 0.00011 3.5 15 2011 220 103975 Polypharmacology Molecules Target Profile
155 TRA@ 1.18e-06 3.5 24 2011 357 103975 Polypharmacology Molecules Target Profile
156 CDC42 0.00074 3.4 12 2011 182 103975 Polypharmacology Molecules Target Profile
157 TUBB 1.33e-17 3.4 75 2011 1166 103975 Polypharmacology Molecules Target Profile
158 MBD2 2.30e-05 3.4 19 2011 290 103975 Polypharmacology Molecules Target Profile
159 MCL1 8.32e-46 3.3 224 2011 3797 103975 Polypharmacology Molecules Target Profile
160 ALOX15B 2.90e-07 3.3 29 2011 459 103975 Polypharmacology Molecules Target Profile
161 ATAD5 2.92e-65 3.3 335 2011 5946 103975 Polypharmacology Molecules Target Profile
162 POLB 9.37e-24 3.3 111 2011 1826 103975 Polypharmacology Molecules Target Profile
163 WHSC1 5.73e-08 3.3 33 2011 530 103975 Polypharmacology Molecules Target Profile
164 BAZ2B 1.17e-59 3.2 317 2011 5745 103975 Polypharmacology Molecules Target Profile
165 GBA 0.0009 3.2 13 2011 214 103975 Polypharmacology Molecules Target Profile
166 CTNNB1 1.72e-05 3.0 23 2011 394 103975 Polypharmacology Molecules Target Profile
167 PTK2 4.16e-09 3.0 43 2011 745 103975 Polypharmacology Molecules Target Profile
168 PTGER2 2.18e-17 3.0 90 2011 1606 103975 Polypharmacology Molecules Target Profile
169 RAC1 0.00027 3.0 17 2011 298 103975 Polypharmacology Molecules Target Profile
170 TACR2 1.46e-07 129.6 5 2011 2 103975 Polypharmacology Molecules Target Profile
171 TOP2A 4.90e-06 103.6 4 2011 2 103975 Polypharmacology Molecules Target Profile
172 THPO 3.66e-07 86.4 5 2011 3 103975 Polypharmacology Molecules Target Profile
173 CALM1 0.00014 77.7 3 2011 2 103975 Polypharmacology Molecules Target Profile
174 CCR5 0.00014 77.7 3 2011 2 103975 Polypharmacology Molecules Target Profile
175 CALM2 0.00014 77.7 3 2011 2 103975 Polypharmacology Molecules Target Profile
176 ERBB2 0.00014 77.7 3 2011 2 103975 Polypharmacology Molecules Target Profile
177 LCK 0.00014 77.7 3 2011 2 103975 Polypharmacology Molecules Target Profile
178 TBXAS1 0.00014 77.7 3 2011 2 103975 Polypharmacology Molecules Target Profile
179 NTSR2 0.00014 77.7 3 2011 2 103975 Polypharmacology Molecules Target Profile
180 FYN 7.91e-07 64.8 5 2011 4 103975 Polypharmacology Molecules Target Profile
181 CCNB1 0.00027 51.8 3 2011 3 103975 Polypharmacology Molecules Target Profile
182 CALM3 0.00027 51.8 3 2011 3 103975 Polypharmacology Molecules Target Profile
183 ARNT 0.0039 51.8 2 2011 2 103975 Polypharmacology Molecules Target Profile
184 MAPK3 0.0039 51.8 2 2011 2 103975 Polypharmacology Molecules Target Profile
185 EGFR 1.54e-08 45.4 7 2011 8 103975 Polypharmacology Molecules Target Profile
186 RXRA 3.66e-05 41.4 4 2011 5 103975 Polypharmacology Molecules Target Profile
187 MTOR 3.45e-07 38.9 6 2011 8 103975 Polypharmacology Molecules Target Profile
188 LHCGR 0.00046 38.8 3 2011 4 103975 Polypharmacology Molecules Target Profile
189 MPHOSPH8 1.58e-07 27.9 7 2011 13 103975 Polypharmacology Molecules Target Profile
190 OPRD1 1.57e-05 25.9 5 2011 10 103975 Polypharmacology Molecules Target Profile
191 ATP1A1 0.0092 25.9 2 2011 4 103975 Polypharmacology Molecules Target Profile
192 ADRA2A 2.69e-06 23.9 6 2011 13 103975 Polypharmacology Molecules Target Profile
193 LMNA 0.0014 22.2 3 2011 7 103975 Polypharmacology Molecules Target Profile
194 ADRA2C 5.47e-05 18.5 5 2011 14 103975 Polypharmacology Molecules Target Profile
195 SLC47A1 0.016 17.3 2 2011 6 103975 Polypharmacology Molecules Target Profile
196 MAPK14 0.016 17.3 2 2011 6 103975 Polypharmacology Molecules Target Profile
197 SLC22A2 0.016 17.3 2 2011 6 103975 Polypharmacology Molecules Target Profile
198 CACNB2 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
199 PARK2 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
200 CASP9 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
201 KIF11 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
202 METAP2 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
203 CACNA2D1 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
204 CES2 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
205 GCK 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
206 PIM2 0.11 17.2 1 2011 3 103975 Polypharmacology Molecules Target Profile
207 ADORA3 1.51e-05 16.4 6 2011 19 103975 Polypharmacology Molecules Target Profile
208 STAT6 9.04e-05 16.2 5 2011 16 103975 Polypharmacology Molecules Target Profile
209 HTR2C 6.80e-07 15.4 8 2011 27 103975 Polypharmacology Molecules Target Profile
210 PPARD 4.04e-06 15.1 7 2011 24 103975 Polypharmacology Molecules Target Profile
211 DRD4 0.019 14.8 2 2011 7 103975 Polypharmacology Molecules Target Profile
212 SIGMAR1 0.019 14.8 2 2011 7 103975 Polypharmacology Molecules Target Profile
213 RGS16 5.01e-06 14.5 7 2011 25 103975 Polypharmacology Molecules Target Profile
214 NFKBIA 0.0039 14.1 3 2011 11 103975 Polypharmacology Molecules Target Profile
215 RGS8 6.22e-06 14.0 7 2011 26 103975 Polypharmacology Molecules Target Profile
216 HTR6 0.00078 13.8 4 2011 15 103975 Polypharmacology Molecules Target Profile
217 RGS7 0.00078 13.8 4 2011 15 103975 Polypharmacology Molecules Target Profile
218 RORC 0.000208 13.0 5 2011 20 103975 Polypharmacology Molecules Target Profile
219 PIN1 0.0048 12.9 3 2011 12 103975 Polypharmacology Molecules Target Profile
220 CHRM2 0.023 12.9 2 2011 8 103975 Polypharmacology Molecules Target Profile
221 ADRB1 0.023 12.9 2 2011 8 103975 Polypharmacology Molecules Target Profile
222 CACNA1D 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
223 CACNA1C 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
224 HRH4 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
225 PLAU 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
226 CACNA1S 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
227 AURKB 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
228 SLC22A1 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
229 SLC47A2 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
230 METAP1 0.13 12.9 1 2011 4 103975 Polypharmacology Molecules Target Profile
231 HTR2B 5.47e-05 12.4 6 2011 25 103975 Polypharmacology Molecules Target Profile
232 RGS19 6.51e-05 12.0 6 2011 26 103975 Polypharmacology Molecules Target Profile
233 HTR2A 6.51e-05 12.0 6 2011 26 103975 Polypharmacology Molecules Target Profile
234 CYP3A5 0.00027 11.8 5 2011 22 103975 Polypharmacology Molecules Target Profile
235 CHRM3 0.0013 11.5 4 2011 18 103975 Polypharmacology Molecules Target Profile
236 CYP3A7 0.0013 11.5 4 2011 18 103975 Polypharmacology Molecules Target Profile
237 HRH2 0.028 11.5 2 2011 9 103975 Polypharmacology Molecules Target Profile
238 OPRM1 4.96e-06 11.2 8 2011 37 103975 Polypharmacology Molecules Target Profile
239 ADRA2B 0.00803 10.4 3 2011 15 103975 Polypharmacology Molecules Target Profile
240 CES1 0.15 10.3 1 2011 5 103975 Polypharmacology Molecules Target Profile
241 CASP8 0.15 10.3 1 2011 5 103975 Polypharmacology Molecules Target Profile
242 PPARA 0.15 10.3 1 2011 5 103975 Polypharmacology Molecules Target Profile
243 MAP3K5 0.15 10.3 1 2011 5 103975 Polypharmacology Molecules Target Profile
244 HSPB1 0.00014 10.0 6 2011 31 103975 Polypharmacology Molecules Target Profile
245 IL8 0.0094 9.7 3 2011 16 103975 Polypharmacology Molecules Target Profile
246 ADORA2A 0.0025 9.4 4 2011 22 103975 Polypharmacology Molecules Target Profile
247 CYP2E1 0.0109 9.1 3 2011 17 103975 Polypharmacology Molecules Target Profile
248 MAOB 0.0109 9.1 3 2011 17 103975 Polypharmacology Molecules Target Profile
249 SLC6A4 0.00306 9.0 4 2011 23 103975 Polypharmacology Molecules Target Profile
250 HK1 0.17 8.6 1 2011 6 103975 Polypharmacology Molecules Target Profile
251 G6PD 0.17 8.6 1 2011 6 103975 Polypharmacology Molecules Target Profile
252 PIM1 0.17 8.6 1 2011 6 103975 Polypharmacology Molecules Target Profile
253 PGR 0.17 8.6 1 2011 6 103975 Polypharmacology Molecules Target Profile
254 CYP2B7P1 0.052 8.0 2 2011 13 103975 Polypharmacology Molecules Target Profile
255 S100A4 0.017 7.4 3 2011 21 103975 Polypharmacology Molecules Target Profile
256 CYP2B6 0.058 7.4 2 2011 14 103975 Polypharmacology Molecules Target Profile
257 AOX1 0.19 7.4 1 2011 7 103975 Polypharmacology Molecules Target Profile
258 CYP2C18 0.19 7.4 1 2011 7 103975 Polypharmacology Molecules Target Profile
259 NR1H4 0.00065 7.2 6 2011 43 103975 Polypharmacology Molecules Target Profile
260 SLC6A2 0.0062 7.1 4 2011 29 103975 Polypharmacology Molecules Target Profile
261 PMM2 0.21 6.5 1 2011 8 103975 Polypharmacology Molecules Target Profile
262 APEX1 0.21 6.5 1 2011 8 103975 Polypharmacology Molecules Target Profile
263 P4HB 0.00064 6.0 7 2011 61 103975 Polypharmacology Molecules Target Profile
264 CYP2D6 0.00029 5.8 8 2011 72 103975 Polypharmacology Molecules Target Profile
265 HTR7 0.23 5.7 1 2011 9 103975 Polypharmacology Molecules Target Profile
266 MMP2 0.00015 5.6 9 2011 84 103975 Polypharmacology Molecules Target Profile
267 HRH1 0.034 5.5 3 2011 28 103975 Polypharmacology Molecules Target Profile
268 HSPA5 0.094 5.4 2 2011 19 103975 Polypharmacology Molecules Target Profile
269 GSTM1 0.00056 5.2 8 2011 80 103975 Polypharmacology Molecules Target Profile
270 MLL 0.04005 5.2 3 2011 30 103975 Polypharmacology Molecules Target Profile
271 CYP1A1 0.101 5.2 2 2011 20 103975 Polypharmacology Molecules Target Profile
272 CNR1 0.101 5.2 2 2011 20 103975 Polypharmacology Molecules Target Profile
273 BCHE 0.26 5.2 1 2011 10 103975 Polypharmacology Molecules Target Profile
274 PRKD1 0.00069 5.0 8 2011 83 103975 Polypharmacology Molecules Target Profile
275 PPARG 0.0017 4.9 7 2011 74 103975 Polypharmacology Molecules Target Profile
276 CTSS 0.057 4.4 3 2011 35 103975 Polypharmacology Molecules Target Profile
277 KDM4C 0.013 4.4 5 2011 59 103975 Polypharmacology Molecules Target Profile
278 ACHE 0.302 4.3 1 2011 12 103975 Polypharmacology Molecules Target Profile
279 EYA2 0.0023 4.1 8 2011 102 103975 Polypharmacology Molecules Target Profile
280 RCE1 0.0049 4.0 7 2011 91 103975 Polypharmacology Molecules Target Profile
281 CYP2C8 0.072 4.0 3 2011 39 103975 Polypharmacology Molecules Target Profile
282 HCRTR2 0.14 4.0 2 2011 26 103975 Polypharmacology Molecules Target Profile
283 MAOA 0.31 4.0 1 2011 13 103975 Polypharmacology Molecules Target Profile
284 DAGLB 0.0108 3.9 6 2011 80 103975 Polypharmacology Molecules Target Profile
285 CTBP1 0.014 3.6 6 2011 86 103975 Polypharmacology Molecules Target Profile
286 BCL2L10 0.022 3.2 6 2011 96 103975 Polypharmacology Molecules Target Profile
287 PLEC 0.11 3.2 3 2011 48 103975 Polypharmacology Molecules Target Profile
288 ERG 0.18 3.2 2 2011 32 103975 Polypharmacology Molecules Target Profile
289 ADRA1D 0.36 3.2 1 2011 16 103975 Polypharmacology Molecules Target Profile
290 ADORA1 0.36 3.2 1 2011 16 103975 Polypharmacology Molecules Target Profile
291 MBNL1 0.068 3.2 4 2011 65 103975 Polypharmacology Molecules Target Profile
292 RAD51 0.041 3.2 5 2011 82 103975 Polypharmacology Molecules Target Profile
293 KDM4A 0.38 3.0 1 2011 17 103975 Polypharmacology Molecules Target Profile
294 ERAP1 0.13 3.0 3 2011 52 103975 Polypharmacology Molecules Target Profile
295 KAT2A 0.00105 2.9 14 2011 247 103975 Polypharmacology Molecules Target Profile
296 PTK2B 0.052 2.9 5 2011 88 103975 Polypharmacology Molecules Target Profile
297 PTPN5 0.00073 2.9 15 2011 266 103975 Polypharmacology Molecules Target Profile
298 TARDBP 3.72e-22 2.9 123 2011 2278 103975 Polypharmacology Molecules Target Profile
299 RGS12 0.22 2.9 2 2011 36 103975 Polypharmacology Molecules Target Profile
300 CYP2A6 0.405 2.9 1 2011 18 103975 Polypharmacology Molecules Target Profile
301 PTGS2 0.405 2.9 1 2011 18 103975 Polypharmacology Molecules Target Profile
302 RAPGEF3 0.0013 2.9 14 2011 254 103975 Polypharmacology Molecules Target Profile
303 DRD1 1.90e-41 2.8 262 2011 5258 103975 Polypharmacology Molecules Target Profile
304 FASN 5.52e-09 2.8 48 2011 901 103975 Polypharmacology Molecules Target Profile
305 LYPLA2 4.26e-05 2.8 24 2011 449 103975 Polypharmacology Molecules Target Profile
306 KCNH2 2.00e-08 2.8 45 2011 850 103975 Polypharmacology Molecules Target Profile
307 SMARCA2 3.82e-13 2.8 76 2011 1461 103975 Polypharmacology Molecules Target Profile
308 EPHB4 0.028 2.7 7 2011 133 103975 Polypharmacology Molecules Target Profile
309 PLA2G3 1.94e-08 2.7 47 2011 910 103975 Polypharmacology Molecules Target Profile
310 PLA2G7 2.26e-15 2.7 97 2011 1951 103975 Polypharmacology Molecules Target Profile
311 ADRBK1 3.36e-06 2.6 35 2011 707 103975 Polypharmacology Molecules Target Profile
312 HBB 0.43 2.6 1 2011 20 103975 Polypharmacology Molecules Target Profile
313 GRM4 0.43 2.6 1 2011 20 103975 Polypharmacology Molecules Target Profile
314 PIP4K2A 5.87e-09 2.6 55 2011 1120 103975 Polypharmacology Molecules Target Profile
315 SLC5A7 2.21e-15 2.6 104 2011 2174 103975 Polypharmacology Molecules Target Profile
316 MRGPRX1 1.41e-21 2.5 153 2011 3275 103975 Polypharmacology Molecules Target Profile
317 ADAM10 2.84e-09 2.5 61 2011 1286 103975 Polypharmacology Molecules Target Profile
318 SENP8 2.52e-18 2.5 135 2011 2959 103975 Polypharmacology Molecules Target Profile
319 DRD2 5.23e-25 2.4 198 2011 4487 103975 Polypharmacology Molecules Target Profile
320 ADAM17 7.08e-09 2.4 63 2011 1387 103975 Polypharmacology Molecules Target Profile
321 ALPL 0.00093 2.4 21 2011 463 103975 Polypharmacology Molecules Target Profile
322 TSHR 1.16e-10 2.3 83 2011 1892 103975 Polypharmacology Molecules Target Profile
323 POLK 0.000504 2.3 25 2011 571 103975 Polypharmacology Molecules Target Profile
324 DUSP3 0.00069 2.3 24 2011 551 103975 Polypharmacology Molecules Target Profile
325 RORA 3.45e-07 2.3 55 2011 1278 103975 Polypharmacology Molecules Target Profile
326 FPR2 0.21 2.2 3 2011 69 103975 Polypharmacology Molecules Target Profile
327 ALPPL2 6.48e-07 2.2 53 2011 1237 103975 Polypharmacology Molecules Target Profile
328 MCOLN1 0.052 2.2 8 2011 186 103975 Polypharmacology Molecules Target Profile
329 LYPLA1 0.046 2.2 9 2011 216 103975 Polypharmacology Molecules Target Profile
330 BCL2L1 7.48e-06 2.2 47 2011 1140 103975 Polypharmacology Molecules Target Profile
331 ABCB6 0.0106 2.1 16 2011 395 103975 Polypharmacology Molecules Target Profile
332 ABCG2 0.091 2.1 7 2011 173 103975 Polypharmacology Molecules Target Profile
333 SLC6A3 7.34e-06 2.1 51 2011 1280 103975 Polypharmacology Molecules Target Profile
334 ARRB1 0.013 2.0 16 2011 406 103975 Polypharmacology Molecules Target Profile
335 SENP6 1.58e-09 2.0 100 2011 2613 103975 Polypharmacology Molecules Target Profile
336 STAT1 3.63e-13 2.0 148 2011 3935 103975 Polypharmacology Molecules Target Profile
337 PRMT1 3.06e-07 2.0 73 2011 1909 103975 Polypharmacology Molecules Target Profile
338 INS 2.07e-06 2.0 63 2011 1647 103975 Polypharmacology Molecules Target Profile
339 KCNK9 6.52e-08 2.0 87 2011 2339 103975 Polypharmacology Molecules Target Profile
340 ATG4B 0.00046 2.0 36 2011 956 103975 Polypharmacology Molecules Target Profile
341 RACGAP1 0.0049 2.0 23 2011 610 103975 Polypharmacology Molecules Target Profile
342 PAFAH2 0.00027 2.0 39 2011 1040 103975 Polypharmacology Molecules Target Profile
343 SLC12A5 3.80e-08 1.9 94 2011 2569 103975 Polypharmacology Molecules Target Profile
344 AHR 8.98e-12 1.9 149 2011 4153 103975 Polypharmacology Molecules Target Profile
345 CASP7 0.16 1.9 6 2011 166 103975 Polypharmacology Molecules Target Profile
346 PLK1 4.97e-11 1.9 152 2011 4374 103975 Polypharmacology Molecules Target Profile
347 RELA 0.403 1.8 2 2011 56 103975 Polypharmacology Molecules Target Profile
348 CGA 0.54 1.8 1 2011 28 103975 Polypharmacology Molecules Target Profile
349 GNAO1 0.00065 1.8 41 2011 1165 103975 Polypharmacology Molecules Target Profile
350 CTSB 0.31 1.8 3 2011 85 103975 Polypharmacology Molecules Target Profile
351 USP2 0.24 1.8 4 2011 114 103975 Polypharmacology Molecules Target Profile
352 TRHR 0.0035 1.8 33 2011 970 103975 Polypharmacology Molecules Target Profile
353 ESR2 0.0032 1.7 35 2011 1042 103975 Polypharmacology Molecules Target Profile
354 EIF2AK3 0.19 1.7 6 2011 182 103975 Polypharmacology Molecules Target Profile
355 KCNK3 0.00306 1.7 39 2011 1195 103975 Polypharmacology Molecules Target Profile
356 EHMT2 6.86e-18 1.7 379 2011 12552 103975 Polypharmacology Molecules Target Profile
357 VCAM1 0.24 1.7 5 2011 155 103975 Polypharmacology Molecules Target Profile
358 UHRF1 0.023 1.7 24 2011 748 103975 Polypharmacology Molecules Target Profile
359 ESR1 0.00012 1.7 73 2011 2301 103975 Polypharmacology Molecules Target Profile
360 EIF4H 0.0035 1.6 44 2011 1405 103975 Polypharmacology Molecules Target Profile
361 SIRT5 0.14 1.6 10 2011 320 103975 Polypharmacology Molecules Target Profile
362 PTBP1 1.87e-06 1.6 128 2011 4194 103975 Polypharmacology Molecules Target Profile
363 YWHAG 0.45 1.6 2 2011 64 103975 Polypharmacology Molecules Target Profile
364 PLA2G1B 0.036 1.6 23 2011 744 103975 Polypharmacology Molecules Target Profile
365 NR4A1 0.405 1.6 3 2011 99 103975 Polypharmacology Molecules Target Profile
366 PABPC1 0.0032 1.5 59 2011 2018 103975 Polypharmacology Molecules Target Profile
367 PTPN7 0.36 1.5 4 2011 137 103975 Polypharmacology Molecules Target Profile
368 ALOX15 0.0806 1.5 21 2011 725 103975 Polypharmacology Molecules Target Profile
369 CTDSP1 0.041 1.5 29 2011 1004 103975 Polypharmacology Molecules Target Profile
370 NR1I2 0.034 1.5 32 2011 1109 103975 Polypharmacology Molecules Target Profile
371 DUSP1 0.43 1.5 3 2011 105 103975 Polypharmacology Molecules Target Profile
372 GFER 7.31e-05 1.5 134 2011 4814 103975 Polypharmacology Molecules Target Profile
373 ALDH1A1 6.23e-08 1.5 277 2011 10267 103975 Polypharmacology Molecules Target Profile
374 ALPI 0.24 1.4 9 2011 324 103975 Polypharmacology Molecules Target Profile
375 PTPN22 0.46 1.4 3 2011 110 103975 Polypharmacology Molecules Target Profile
376 GLS 0.38 1.4 5 2011 186 103975 Polypharmacology Molecules Target Profile
377 TRPV1 0.38 1.4 5 2011 186 103975 Polypharmacology Molecules Target Profile
378 HPGD 0.00058 1.4 151 2011 5839 103975 Polypharmacology Molecules Target Profile
379 CACNA1H 0.0053 1.3 103 2011 4004 103975 Polypharmacology Molecules Target Profile
380 WEE1 0.101 1.3 32 2011 1233 103975 Polypharmacology Molecules Target Profile
381 SENP7 0.033 1.3 66 2011 2608 103975 Polypharmacology Molecules Target Profile
382 BAP1 0.406 1.3 7 2011 281 103975 Polypharmacology Molecules Target Profile
383 TMPRSS15 0.69 1.3 1 2011 41 103975 Polypharmacology Molecules Target Profile
384 CCT2 0.69 1.3 1 2011 41 103975 Polypharmacology Molecules Target Profile
385 CASP3 0.11 1.3 50 2011 2071 103975 Polypharmacology Molecules Target Profile
386 KPNA2 0.49 1.2 5 2011 210 103975 Polypharmacology Molecules Target Profile
387 CDC25B 0.61 1.2 2 2011 84 103975 Polypharmacology Molecules Target Profile
388 GSK3A 0.405 1.2 10 2011 422 103975 Polypharmacology Molecules Target Profile
389 EPHX2 0.44 1.2 8 2011 341 103975 Polypharmacology Molecules Target Profile
390 GAA 0.28 1.2 28 2011 1218 103975 Polypharmacology Molecules Target Profile
391 MAP3K3 0.18 1.2 62 2011 2759 103975 Polypharmacology Molecules Target Profile
392 GSK3B 0.55 1.2 5 2011 222 103975 Polypharmacology Molecules Target Profile
393 PRKACA 0.65 1.2 2 2011 89 103975 Polypharmacology Molecules Target Profile
394 CTSG 0.66 1.1 2 2011 91 103975 Polypharmacology Molecules Target Profile
395 PTPN11 0.73 1.1 1 2011 46 103975 Polypharmacology Molecules Target Profile
396 BRCA1 0.38 1.1 40 2011 1876 103975 Polypharmacology Molecules Target Profile
397 PAFAH1B2 0.45 1.1 31 2011 1477 103975 Polypharmacology Molecules Target Profile
398 MMP13 0.76 1.1 1 2011 49 103975 Polypharmacology Molecules Target Profile
399 APOBEC3A 0.65 1.0 9 2011 454 103975 Polypharmacology Molecules Target Profile
400 CLK1 0.78 1.0 1 2011 51 103975 Polypharmacology Molecules Target Profile
401 F2 0.68 1.0 7 2011 358 103975 Polypharmacology Molecules Target Profile
402 KLK7 0.65 1.0 26 2011 1337 103975 Polypharmacology Molecules Target Profile
403 PKM 0.73 1.0 10 2011 534 103975 Polypharmacology Molecules Target Profile
404 PLCB3 0.73 1.0 7 2011 379 103975 Polypharmacology Molecules Target Profile
405 PHOSPHO1 0.83 0.9 41 2011 2252 103975 Polypharmacology Molecules Target Profile
406 FGF22 0.77 0.9 9 2011 497 103975 Polypharmacology Molecules Target Profile
407 MARVELD2 0.86 0.9 6 2011 363 103975 Polypharmacology Molecules Target Profile
408 PLCG1 0.98 0.8 21 2011 1295 103975 Polypharmacology Molecules Target Profile
409 ROCK2 0.92 0.8 3 2011 203 103975 Polypharmacology Molecules Target Profile
410 KLK5 0.99 0.7 14 2011 967 103975 Polypharmacology Molecules Target Profile
411 CYP2C9 0.99 0.7 300 2011 19842 103975 Polypharmacology Molecules Target Profile
412 RXFP1 0.93 0.7 2 2011 142 103975 Polypharmacology Molecules Target Profile
413 PTH1R 0.95 0.7 2 2011 150 103975 Polypharmacology Molecules Target Profile
414 F12 0.99 0.7 7 2011 535 103975 Polypharmacology Molecules Target Profile
415 CREBBP 0.96 0.6 1 2011 81 103975 Polypharmacology Molecules Target Profile
416 SMN2 0.99 0.6 49 2011 4000 103975 Polypharmacology Molecules Target Profile
417 TSG101 0.98 0.6 1 2011 85 103975 Polypharmacology Molecules Target Profile
418 AKT1 0.99 0.6 12 2011 1114 103975 Polypharmacology Molecules Target Profile
419 CYP2C19 0.99 0.5 232 2011 20096 103975 Polypharmacology Molecules Target Profile
420 DRD5 0.99 0.5 1 2011 101 103975 Polypharmacology Molecules Target Profile
421 NPC1 0.99 0.5 33 2011 3335 103975 Polypharmacology Molecules Target Profile
422 MAPK10 0.99 0.4 3 2011 347 103975 Polypharmacology Molecules Target Profile
423 NR0B1 0.99 0.4 15 2011 1902 103975 Polypharmacology Molecules Target Profile
424 RAB9A 0.99 0.4 29 2011 4056 103975 Polypharmacology Molecules Target Profile
425 FPR1 0.99 0.3 1 2011 171 103975 Polypharmacology Molecules Target Profile
426 ABCC1 0.99 0.2 3 2011 846 103975 Polypharmacology Molecules Target Profile
427 F11 0.99 0.2 1 2011 293 103975 Polypharmacology Molecules Target Profile
428 ALOX5 0.99 0.0 0 2011 7 103975 Polypharmacology Molecules Target Profile
429 TYMS 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
430 C1S 0.99 0.0 0 2011 97 103975 Polypharmacology Molecules Target Profile
431 ID4 0.99 0.0 0 2011 29 103975 Polypharmacology Molecules Target Profile
432 CNR2 0.99 0.0 0 2011 7 103975 Polypharmacology Molecules Target Profile
433 CA5A 0.99 0.0 0 2011 18 103975 Polypharmacology Molecules Target Profile
434 MMP12 0.99 0.0 0 2011 5 103975 Polypharmacology Molecules Target Profile
435 CA13 0.99 0.0 0 2011 7 103975 Polypharmacology Molecules Target Profile
436 NOX1 0.99 0.0 0 2011 13 103975 Polypharmacology Molecules Target Profile
437 MYC 0.99 0.0 0 2011 25 103975 Polypharmacology Molecules Target Profile
438 SMPD1 0.99 0.0 0 2011 10 103975 Polypharmacology Molecules Target Profile
439 SLC12A1 0.99 0.0 0 2011 5 103975 Polypharmacology Molecules Target Profile
440 GLA 0.99 0.0 0 2011 19 103975 Polypharmacology Molecules Target Profile
441 UGT2B7 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
442 AVPR1B 0.99 0.0 0 2011 57 103975 Polypharmacology Molecules Target Profile
443 GRM5 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
444 PTGIR 0.99 0.0 0 2011 8 103975 Polypharmacology Molecules Target Profile
445 SLC12A3 0.99 0.0 0 2011 9 103975 Polypharmacology Molecules Target Profile
446 PDE3A 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
447 CYP11B2 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
448 HTR1B 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
449 HTR1D 0.99 0.0 0 2011 8 103975 Polypharmacology Molecules Target Profile
450 GPR32 0.99 0.0 0 2011 19 103975 Polypharmacology Molecules Target Profile
451 CA4 0.99 0.0 0 2011 22 103975 Polypharmacology Molecules Target Profile
452 ADRA1A 0.99 0.0 0 2011 8 103975 Polypharmacology Molecules Target Profile
453 IDO1 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
454 MEN1 0.99 0.0 0 2011 5 103975 Polypharmacology Molecules Target Profile
455 SHBG 0.99 0.0 0 2011 18 103975 Polypharmacology Molecules Target Profile
456 HSD11B1 0.99 0.0 0 2011 12 103975 Polypharmacology Molecules Target Profile
457 PTGER4 0.99 0.0 0 2011 9 103975 Polypharmacology Molecules Target Profile
458 ABCC8 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
459 MMP9 0.99 0.0 0 2011 5 103975 Polypharmacology Molecules Target Profile
460 AKR1C3 0.99 0.0 0 2011 10 103975 Polypharmacology Molecules Target Profile
461 AKR1C2 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
462 PDE4B 0.99 0.0 0 2011 7 103975 Polypharmacology Molecules Target Profile
463 PTPN1 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
464 MPO 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
465 CA14 0.99 0.0 0 2011 21 103975 Polypharmacology Molecules Target Profile
466 UGT1A3 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
467 SCN5A 0.99 0.0 0 2011 9 103975 Polypharmacology Molecules Target Profile
468 CA5B 0.99 0.0 0 2011 16 103975 Polypharmacology Molecules Target Profile
469 KCNMA1 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
470 AKR1C1 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
471 UGT1A1 0.99 0.0 0 2011 5 103975 Polypharmacology Molecules Target Profile
472 CA9 0.99 0.0 0 2011 28 103975 Polypharmacology Molecules Target Profile
473 CYP1B1 0.99 0.0 0 2011 10 103975 Polypharmacology Molecules Target Profile
474 AKR1B1 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
475 RXFP2 0.99 0.0 0 2011 55 103975 Polypharmacology Molecules Target Profile
476 UGT1A9 0.99 0.0 0 2011 8 103975 Polypharmacology Molecules Target Profile
477 NR3C2 0.99 0.0 0 2011 7 103975 Polypharmacology Molecules Target Profile
478 PTGS1 0.99 0.0 0 2011 19 103975 Polypharmacology Molecules Target Profile
479 PDE4A 0.99 0.0 0 2011 8 103975 Polypharmacology Molecules Target Profile
480 XIAP 0.99 0.0 0 2011 18 103975 Polypharmacology Molecules Target Profile
481 PTGDR 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
482 CA12 0.99 0.0 0 2011 26 103975 Polypharmacology Molecules Target Profile
483 KEAP1 0.99 0.0 0 2011 7 103975 Polypharmacology Molecules Target Profile
484 GPER 0.99 0.0 0 2011 19 103975 Polypharmacology Molecules Target Profile
485 CA2 0.99 0.0 0 2011 30 103975 Polypharmacology Molecules Target Profile
486 PTGDR2 0.99 0.0 0 2011 6 103975 Polypharmacology Molecules Target Profile
487 SMN1 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
488 EZH2 0.99 0.0 0 2011 7 103975 Polypharmacology Molecules Target Profile
489 ADORA2B 0.99 0.0 0 2011 9 103975 Polypharmacology Molecules Target Profile
490 CYP11B1 0.99 0.0 0 2011 8 103975 Polypharmacology Molecules Target Profile
491 PDE5A 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
492 HTR1F 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
493 CA7 0.99 0.0 0 2011 19 103975 Polypharmacology Molecules Target Profile
494 ADRA1B 0.99 0.0 0 2011 5 103975 Polypharmacology Molecules Target Profile
495 GABRA1 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
496 CA1 0.99 0.0 0 2011 33 103975 Polypharmacology Molecules Target Profile
497 CA3 0.99 0.0 0 2011 14 103975 Polypharmacology Molecules Target Profile
498 CA6 0.99 0.0 0 2011 18 103975 Polypharmacology Molecules Target Profile
499 GRM1 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
500 FKBP1A 0.99 0.0 0 2011 22 103975 Polypharmacology Molecules Target Profile
501 HSD17B1 0.99 0.0 0 2011 5 103975 Polypharmacology Molecules Target Profile
502 ERAP2 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
503 PTPN12 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile
504 SCN9A 0.99 0.0 0 2011 4 103975 Polypharmacology Molecules Target Profile